All News

The Biden administration released the list of 27 Medicare Part B drugs that are subject to rebates back to the government for having price increases that rose faster than inflation as well as the removal of out-of-pocket costs for some vaccines covered under Part D.

Lee A. Norman, MD, MHS, MBA, spoke at The American Journal of Managed Care® (AJMC®)’s Institute for Value-Based Medicine®'s March 2023 event on population health about leading physician practices and navigating through change; here, he talks about how the COVID-19 pandemic shifted how he thinks about resiliency during times of intense stress and work.

The device, PEP Buddy improves breathlessness symptoms and quality of life in patients with chronic obstructive pulmonary disease (COPD), as well as people who have anxiety and stress.

In this new analysis, investigators found significant agreement between in-person and remote assessments.

The US Department of Veterans Affairs (VA) will cover Alzheimer drug lecanemab (Leqembi) based on inclusion criteria approval and other factors; Pfizer Inc. will buy drug maker Seagen Inc. and their targeted cancer drugs for $43 billion; Novo Nordisk will reduce its insulin costs by up to 75%, and also plans to discount other drugs.

A recent study conducted in Norway found that too much or too little self-reported sleep was associated with 44% and 25% greater risk of infection, respectively, and higher antibiotic use.

Investigators said several new anemia therapies are in development, and many of them may help wide swaths of patients.

Patients who had ruxolitinib added to their prophylactic regimens had lower rates of acute and chronic graft-versus-host disease (GVHD).

In this new study, vaccine efficiency calculations were determined by the amount of heterogeneous and homogenous contact had by vaccinated individuals.

People with muscle-specific kinase myasthenia gravis appear to have more active antibody responses in general, the study found.

Manmeet Ahluwalia, MD, MBA, chief, Solid Tumor Medical Oncology; deputy director; and chief scientific officer at Miami Cancer Institute, addressed disparities in genomic testing among minority patients with cancer, as well as equitable care strategies at his organization’s Center for Equity in Cancer Care & Research.

Abstracts presented at the American Academy of Allergy, Asthma & Immunology conference examined how ethnic and language barriers in respiratory care affect Hispanic patients, with results showing the need for improved asthma care.

Using a clustering algorithm, researchers were able to identify inflammatory and noninflammatory subsets of the disease, which may account for varying responses to certain treatments.

The researchers noted that their study is the first to assess the ability of noninvasive variables, both resting- and exercise-based, to identify pulmonary hypertension in interstitial lung disease.

A group of researchers detailed a case of acquired hemophilia A (AHA) following infection and again following vaccination, and provided additional insights through their systematic review of available data.

A new report found only about 2.8% of people with myelodysplastic syndromes (MDS) have JAK2 mutations.

Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, spoke on antibiotic use and other risk factors for the development of Clostridioides difficile infection.

The authors said it is the first study of epidemiology and real-world treatment in Germany.

Members of the Association of Community Cancer Centers (ACCC) Alternative Payment Coalition discussed strategies for succeeding in value-based care and voiced concerns surrounding the upcoming Enhancing Oncology Model (EOM) during a panel discussion at the ACCC 2023 Annual Meeting and Business Summit.

The findings, published in the Journal of the National Comprehensive Cancer Network, add to the evidence that the shift to precision medicine is built on data that have not included sufficient numbers of patients of color.

A session at the Association of Community Cancer Centers (ACCC) 2023 Annual Meeting and Cancer Center Business Summit highlighted ongoing issues in oncology policy and payment, from the Cures 2.0 Act to 340B drug reimbursement.

Body mass index and nadir CD4 count were major factors in SARS-CoV-2 humoral immune repertoire among people with HIV.

In a recent webinar, health care experts discussed how addressing social determinants of health by investing in various areas can benefit patients and payers.

When a series of winter storms in Austin, Texas, in February 2021, 62% of children with epilepsy were negatively affected, according to a new study.

Jeff Hunnicutt, CEO of Highlands Oncology Group, explains the 2 risk options provided under the Enhancing Oncology Model (EOM) and why the mandatory downside risk might give pause to practices that saw some success in the Oncology Care Model.

A meta-analysis and review of 9 randomized trials found high-quality evidence demonstrating the benefits of dupilumab in patients with severe atopic dermatitis.

These new findings suggest that variability in factor VIII (FVIII) half-life in patients, though impacted by all 3 factors, is largely attributed to variability in the clearance of endogenous von Willebrand factor (VWF).

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.